Arcellx (ACLX) Equity Average (2021 - 2025)
Arcellx (ACLX) recorded quarterly Equity Average of $421.6 million in Q4 2025, up 1.22% quarter-over-quarter from $416.5 million in Q3 2025, and down 10.1% on a YoY basis from $468.9 million in Q4 2024.
Arcellx (ACLX) Equity Average (2021 - 2025) Analysis & Trends
Arcellx's Equity Average history runs 5 years deep, the most recent figure standing at $421.6 million for Q4 2025.
- In Q4 2025, Equity Average fell 10.1% year-over-year to $421.6 million; the TTM figure through Dec 2025 stood at $421.6 million (down 10.1% YoY), while the FY2025 annual figure was $428.6 million, down 8.83% from the prior year.
- Equity Average was $421.6 million for Q4 2025 at Arcellx, up from $416.5 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $491.9 million in Q2 2024 to a low of -$112.7 million in Q4 2021.
- Historically, Equity Average has averaged $260.7 million across 5 years, with a median of $298.7 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Equity Average surged 2298.68% in 2023, then fell 17.75% in 2025.
- A 5-year view of Equity Average shows it stood at -$112.7 million in 2021, then surged by 113.91% to $15.7 million in 2022, then soared by 2298.68% to $375.8 million in 2023, then gained by 24.79% to $468.9 million in 2024, then declined by 10.1% to $421.6 million in 2025.
- The last three Equity Average figures came in at $421.6 million (Q4 2025), $416.5 million (Q3 2025), and $404.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 421.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 421.56 Mn |
| Sep 30, 2025 | 416.50 Mn |
| Jun 30, 2025 | 404.56 Mn |
| Mar 31, 2025 | 435.85 Mn |
| Dec 31, 2024 | 468.91 Mn |
| Sep 30, 2024 | 485.09 Mn |
| Jun 30, 2024 | 491.87 Mn |
| Mar 31, 2024 | 490.98 Mn |
| Dec 31, 2023 | 375.75 Mn |
| Sep 30, 2023 | 279.90 Mn |
| Jun 30, 2023 | 298.69 Mn |
| Mar 31, 2023 | 49.38 Mn |
| Dec 31, 2022 | 15.67 Mn |
| Sep 30, 2022 | 279.95 Mn |
| Jun 30, 2022 | 275.78 Mn |
| Mar 31, 2022 | 53.21 Mn |
| Dec 31, 2021 | -112.66 Mn |
| Sep 30, 2021 | -96.27 Mn |
| Jun 30, 2021 | -81.49 Mn |